3 SEHK Growth Stocks With Up To 25% Insider Ownership

In This Article:

The Hong Kong market has recently seen a boost, with the Hang Seng Index gaining over 5% in response to the U.S. Federal Reserve's rate cut, despite some mixed economic data from China. This optimistic environment makes it an opportune time to explore growth companies with significant insider ownership, which can be a positive indicator of confidence and alignment between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

Laopu Gold (SEHK:6181)

36.4%

34.7%

Akeso (SEHK:9926)

20.5%

54.7%

Fenbi (SEHK:2469)

33.1%

22.4%

Zylox-Tonbridge Medical Technology (SEHK:2190)

18.8%

69.8%

Pacific Textiles Holdings (SEHK:1382)

11.2%

37.7%

Zhejiang Leapmotor Technology (SEHK:9863)

15%

78.9%

DPC Dash (SEHK:1405)

38.2%

104.2%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

13.9%

109.2%

Beijing Airdoc Technology (SEHK:2251)

29.1%

93.4%

MicroTech Medical (Hangzhou) (SEHK:2235)

25.8%

105%

Click here to see the full list of 47 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Alibaba Health Information Technology

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Alibaba Health Information Technology Limited operates in pharmaceutical direct sales, pharmaceutical e-commerce platforms, and healthcare and digital services in Mainland China and Hong Kong, with a market cap of HK$50.50 billion.

Operations: The company generates revenue primarily from the distribution and development of pharmaceutical and healthcare business, amounting to CN¥27.03 billion.

Insider Ownership: 19.3%

Alibaba Health Information Technology is poised for significant earnings growth, with forecasts suggesting a 23.9% annual increase over the next three years, outpacing the Hong Kong market's 11.8%. Despite recent shareholder dilution and low forecasted return on equity (13.7%), the stock trades at a substantial discount to its estimated fair value. The company has experienced robust revenue growth (10.8% annually) and recently underwent executive changes, with Mr. Zhu Shunyun transitioning to a non-executive role while remaining Chairman of the Board.

SEHK:241 Earnings and Revenue Growth as at Sep 2024
SEHK:241 Earnings and Revenue Growth as at Sep 2024

Meituan

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Meituan operates as a technology retail company in the People’s Republic of China with a market cap of approximately HK$802.90 billion.